Cargando…
Rac1 as a multifunctional therapeutic target to prevent and combat cancer metastasis
Metastatic progression of malignant tumors resistant to conventional therapeutic approaches is an ultimate challenge in clinical oncology. Despite the efforts of basic and clinical researchers, there is still no effective treatment schedule to prevent or combat metastatic spread of malignant tumors....
Autores principales: | Arnold, Christoph R., Abdelmoez, Alshaimaa, Thurner, Gudrun, Debbage, Paul, Lukas, Peter, Skvortsov, Sergej, Skvortsova, Ira-Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278326/ https://www.ncbi.nlm.nih.gov/pubmed/25594058 |
Ejemplares similares
-
Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014) -
Nanomedicine Faces Barriers
por: Debbage, Paul, et al.
Publicado: (2010) -
Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later
por: Thurner, Gudrun C., et al.
Publicado: (2018) -
Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2017) -
Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2019)